AJP - Regu Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 275: R742-R753, 1998;
0363-6119/98 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Teng, G. Q.
Right arrow Articles by Pearce, W. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Teng, G. Q.
Right arrow Articles by Pearce, W. J.
Vol. 275, Issue 3, R742-R753, September 1998

Effects of maturation, artery size, and chronic hypoxia on 5-HT receptor type in ovine cranial arteries

Guo Qi Teng1, James Williams1, Lubo Zhang1, Ralph Purdy2, and William J. Pearce1

1 Center for Perinatal Biology, Departments of Physiology and Pharmacology, Loma Linda University School of Medicine, Loma Linda 92350, and 2 Department of Pharmacology, University of California at Irvine, Irvine, California 92697-4625

    ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

To test the hypothesis that variations in cerebrovascular reactivity to 5-HT among arteries of different size or type, during maturation, or during acclimatization to high altitude involve differences in serotonergic receptor subtype, we determined relative agonist potency orders and antagonist affinities in common carotid (Com), main branch middle cerebral (Main), and second branch middle cerebral (2BR) arteries from term fetal lambs and nonpregnant adult sheep acclimatized at sea level or at an altitude of 3,820 m for approx 110 days. In normoxic adult Com segments, agonist potency order was 5-hydroxytryptamine (5-HT) > 5-carboxamidotryptamine (5-CT) >=  8-hydroxy-2(di-n-propylamino)tetraline (8-OH-DPAT); sumatriptan (Suma) produced no contractile response; and antagonist dissociation constant (pKb) values were 9.4 and 9.5 for ketanserin against 5-HT and 5-CT, 7.5 for GR-127935 against 5-HT, and 7.2 for SB-206553 against 5-HT. In normoxic adult Main segments, agonist potency order was 5-HT > 5-CT >=  Suma >=  DPAT, and pKb values were 9.1 and 9.2 for ketanserin against 5-HT and 5-CT and 7.4 and 8.5 for GR-127935 against 5-HT and Suma, respectively. In the 2BR segments from normoxic adults, agonist potency order was 5-CT > 5-HT > Suma > DPAT and pKb values were 7.4 and 7.2 for ketanserin against 5-HT and 5-CT and 10.0 and 8.7 for GR-127935 against 5-HT and Suma, respectively. Compared with normoxic adults, none of these values were significantly different in hypoxic adults and in fetuses only the pKb values for ketanserin against 5-HT in the 2BR segments (8.8) were greater. From these results we propose that the ratio of 5-HT2 to 5-HT1 receptors is greatest in the Com and decreases progressively to its smallest values in 2BR or smaller segments. Because this gradient appears stable and relatively resistant to the effects of maturation and chronic hypoxia, changes in reactivity associated with these perturbations may involve alterations in receptor density and/or coupling efficiency for 5-HT in ovine cranial arteries.

5-carboxamidotryptamine; 5-hydroxytryptamine types 1 and 2; 8-hydroxy-2(di-n-propylamino)tetraline; cerebral arteries; cerebrovascular circulation; GR-127935; hypoxia; ketanserin; maturation; methiothepin; SB-206553; sumatriptan; sheep

    INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

SEROTONIN'S MANY cerebrovascular effects include responses of both physiological and pathophysiological importance. Perivascular serotonergic nerves may help couple cerebral metabolism and perfusion (5) and may also contribute to migraine (28). Serotonin participates in cerebrovascular responses to aggregating platelets and may also contribute to development of the vasospasm that typically follows intracranial hemorrhages (38). Although the exact role of serotonin in many cerebrovascular responses remains under investigation, its importance in the cerebral vasculature seems certain.

Perhaps as a consequence of the many diverse cerebral functions of serotonin, cerebrovascular reactivity to this agonist is not static and instead can be modulated by many influences. Acclimatization to chronic hypoxia alters cerebrovascular reactivity to serotonin and other amines (26), as do pregnancy (20) and maturation (45). Cerebrovascular reactivity to serotonin and other amines also varies in relation to artery size and type (10, 45). Although the extent and nature of this variability is well documented, the mechanisms responsible remain unclear.

Aside from factors such as contractile protein content and intracellular calcium pool size that govern overall contractile capacity, one of the most important determinants of arterial reactivity to any agonist is the receptor type to which it binds. Indeed, shifts in receptor type are often closely associated with shifts in vascular function. For example, the receptor mediating responses to norepinephrine shifts from the alpha 1-subtype in large arteries to the alpha 2-subtype in small arteries (23, 24). Given the importance of receptor type in determining reactivity, it is possible that changes in serotonergic reactivity related to differences in artery size, type, age, and hypoxic exposure could also be associated with shifts in receptor type. The present experiments were conducted to evaluate these possibilities.

Serotonergic receptors at present are categorized into seven main families, of which the 5-hydroxytryptamine types 1 and 2 (5-HT1 and 5-HT2, respectively) families most commonly mediate contractile responses to 5-HT in vascular smooth muscle (18, 19, 39). Within these two main receptor families, at least five different 5-HT1 subtypes and three different 5-HT2 subtypes have been pharmacologically characterized and cloned (39). To examine how these various 5-HT receptor types might vary with cerebral artery type (or origin) and diameter, all experiments were carried out in common carotid (Com), main branch middle cerebral arteries (Main), and second branch order segments (2BR) of middle cerebral arteries. Owing to its extracranial origin, the Com was expected to be more similar to peripheral, than to cerebral, arteries. To examine how 5-HT receptor type can vary with maturation, arteries from both term fetal lambs and nonpregnant adult sheep were studied. To examine how hypoxic acclimatization can influence 5-HT receptor type we also examined arteries from nonpregnant adult sheep acclimatized at an altitude of 3,820 m for approx 110 days. To identify the serotonergic receptors involved in each of these experimental groups, we determined both relative agonist potencies and antagonist affinities according to the criteria established by Hoyer et al. (18, 19). With the use of these approaches, we investigated the extent to which maturation, chronic hypoxia, artery size, and artery type affect 5-HT receptor type in the ovine cerebral circulation.

    MATERIALS AND METHODS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

General methods. For these studies, we examined Com, Main, and 2BR arteries from adult rams and nonpregnant ewes that had been maintained near sea level or at high altitude (3,820 m; Barcroft Laboratory, White Mountain Research Station, Bishop, CA) for approx 110 days (arterial PO2 approx  64 Torr) as well as near-term normoxic fetal sheep (139-141 days gestation) using methods previously described (10, 33). Both males and females were included in the normoxic fetus group, only nonpregnant fully mature ewes (24 mo or older) were included in the hypoxic adult group, and the normoxic adult group consisted mainly of nonpregnant fully mature ewes with inclusion of a few young males (18-24 mo). Statistical comparisons of basic characteristics, such as reactivity to 5-HT, maximum responses to potassium, and maximum responses to endothelium-dependent vasodilators, as previously described (33), were performed and verified that no significant differences existed between animals of different sex.

Briefly, after the initial dissection and removal of excess adipose and connective tissue, we cut the arteries into individual ring segments 1-3 mm long. To avoid endothelial influences, we removed the endothelium by mechanical abrasion achieved in Com and Main segments by carefully passing a small needle through the lumen and in 2BR segments by passing a human hair through the lumen of the vessels several times. We then mounted the segments on paired tungsten wires (OD 250 µm for Com, 125 µm for Main, and 24 µm for 2BR) between a low-compliance force transducer (Kulite BG-10) and a post attached to a micrometer used to vary resting tension. We equilibrated the arteries at 38.5°C (normal ovine core temperature) for at least 30 min in baths superfused with a bicarbonate Krebs solution containing (in mM) 120 NaCl, 5.56 dextrose, 25.6 NaHCO3, 5.17 KCl, 2.49 MgSO4, and 1.60 CaCl2, in addition to 114 µM ascorbic acid and 27 µM disodium EDTA. The baths were continuously bubbled with 95% O2-5% CO2. We obtained micrometer readings for each segment under unstressed conditions (100 mg total tension in Com and Main; 10 mg in 2BR) and calculated unstressed diameter as twice the distance between the two wires divided by pi. For 2BR segments, optimum diameter was taken as 2.9 and 2.2 times unstressed diameter in adult and fetal segments, respectively, which in our previous studies has proven to be optimum in terms of both reproducibility and maximum force generation (10). This extent of stretch yielded resting tensions of approx 150-250 mg. Com and Main segments were stretched until resting tensions of 1.0 and 0.5 g were attained, respectively. During all contractility experiments the contractile tensions from all artery segments were continuously recorded on both an ink-writing oscillograph (model 8373-20 recorder, Cole-Parmer Instrument) and an online computer, which digitized and normalized the data.

After 30 min of equilibration at optimum stretch, we contracted all arteries with a potassium-Krebs solution similar to that described above, with the exception that NaCl was eliminated and exchanged for KCl on an equimolar basis that yielded a final potassium ion concentration of 120 mM. Exposure to potassium-Krebs was repeated until reproducible maximal contractions were obtained, which generally required two or three exposures. The arteries were then contracted with either 10 µM 5-HT (Com and Main) or UTP (2BR) segments. UTP was used in the 2BR segments because it produced a much more stable contractile response than that to 5-HT. Once agonist-induced tone had stabilized, the arteries were then exposed to either 1 µM ADP (Com and Main) or 1 µM acetylcholine (2BR). ADP was used in Com and Main segments because it is the most potent endothelium-dependent relaxant we have found in these artery types. Correspondingly, acetylcholine was used in the 2BR segments for similar reasons. Arteries of either type exhibiting relaxations >10% to ADP or acetylcholine were discarded.

Agonist dose-response measurements. After verification of endothelial denudation, the arteries were equilibrated for another 30 min at optimum stretch in normal Krebs to which we added 0.1 µM prazosin and 0.2 µM cocaine to block any possible effect of alpha 1-receptors and neuronal uptake, respectively. Thirty minutes later, cumulative concentration-response curves were generated for 5-HT; 5-carboxamidotryptamine (5-CT), a preferential agonist of 5-HT1A and 5-HT1E receptors; 8-hydroxy-2(di-n-propylamino)tetraline (8-OH-DPAT), a preferential agonist of 5-HT1A receptors; and sumatriptan (Suma), a preferential agonist of the h1B and 1D serotonergic subtypes. Each agent was added in half-log increments from 0.1 nM to 100 µM. Each segment was used to determine only one concentration-response relation to only one agonist. On completion of the concentration-response determinations, the contractile data were normalized relative to the maximal response to potassium and then fitted to the logistic equation using nonlinear regression to obtain pD2 values (-log EC50) and the maximal contractile responses (Emax) for each agonist.

Determination of antagonist pKb values. In preliminary experiments, 5-HT caused significant desensitization in repeated concentration-effect determinations. To avoid this effect, which violates classical Schild conditions, we determined antagonist dissociation constants (pKb) by comparing concentration-effect curves obtained from control and antagonist treatments in paired adjacent artery segments. Owing to the large number of antagonist-agonist combinations employed, tissue availability could not accommodate allocation of more than one or two artery segments from each animal to determination of each estimate of antagonist affinity. Therefore, pKb values were determined instead of pA2 values, which require analysis of the effects of multiple concentrations of anatogonist using a Schild plot.

To normalize for segment-to-segment differences in contractile capacity, all responses were normalized relative to the maximum response within each segment to 120 mM potassium-Krebs. Given the reasonable assumption that equal magnitudes of response corresponded to equal numbers of agonist-receptor interactions in adjacent segments from the same artery, we then calculated equieffective dose ratios between control and antagonist-treated segments at the pD2 concentration of the antagonist-treated segments. For this calculation, we determined coefficients for the logistic equation for both control and antagonist-treated arteries and then solved for the concentration in the untreated control segments, which produced the tension observed at the pD2 concentration in the antagonist-treated segments. Because this approach meets the general requirements necessary for a Schild analysis, we then used the Furchgott equation to determine pKb: [A']/[A] = 1 + ([B]/KB) where [A] is the concentration of agonist in the control tissues, [A'] is the concentration of agonist in the blocked tissues at the pD2, [B] is the concentration of antagonist, and pKb is the -log KB. In this manner, each estimate of pKb was obtained from a matched pair of artery segments, one treated with the antagonist and the other served as the control. The antagonists used included the 5-HT2A-selective antagonist ketanserin, the mixed 5-HT1/5-HT2 antagonist methiothepin, the 5-HTh1B- and 5-HT1D-selective antagonist GR-127935, and the selective 5-HT2B/5-HT2C antagonist SB-206553.

Data analysis and statistics. The data are expressed throughout the paper as means ± SE. Significant differences in agonist potency (pD2) and Emax among 5-CT, 5-HT, 8-OH-DPAT, and Suma were evaluated using ANOVA techniques followed by a Duncan's multiple-range analysis. Given that pooled variances for common carotid pD2 and Emax values were significantly different than observed in the cerebral arteries (Main and 2BR), the common and cerebral arteries were analyzed separately. Comparisons between the different agonists were performed using the Duncan's multiple-range analysis at the P < 0.05 level. Significant differences in antagonist affinities (pKb) were analyzed using two-way ANOVAs with experimental group as one factor and artery type as the other. Each antagonist was analyzed separately. Comparisons of pKb values among experimental groups and among agonists were performed using a Duncan's post hoc analysis. Unless indicated otherwise, statistical significance was taken at the P < 0.05 level.

Drugs. The drugs used were 5-HT, 8-OH-DPAT, cocaine hydrochloride, prazosin, UTP, acetylcholine (all from Sigma); methiothepin, ketanserin, 5-CT, and SB-206553 (all from Research Biochemicals); and Suma and GR-127935 (supplied by Glaxco Pharmaceuticals). Stock solutions of all drugs were made using distilled water, were stored as aliquots at -20°C until time of use, and were never frozen more than once.

    RESULTS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

General results. From a total of 41 normoxic adults, 34 normoxic fetuses, and 29 hypoxic adults, a total of 380 Com, 313 Main, and 346 2BR artery segments were taken for study. Com segment diameters averaged ~3.0 mm in adults and 2.6 mm in fetuses. Main diameters averaged ~640 µm in adults and 470 µm in fetuses. For 2BR segments, the diameters averaged 201 ± 3 µm in normoxic adults, 197 ± 5 µm in hypoxic adults, and 203 ± 3 µm in normoxic fetuses. The maximal contractile tensions produced by these arteries in response to 120 mM KCl averaged 6.2 ± 0.2 g in Com segments, 3.4 ± 0.1 g in Main segments, and 0.63 ± 0.01 g in 2BR segments. When precontracted with 1 µM 5-HT (Com and Main) or 20 µM UTP (2BR), neither 10 µM ADP (Com and Main) nor 1 µM acetylcholine (2BR) produced any significant vasodilatation, indicating that endothelium removal was effective and complete.

Agonist potencies. In Com arteries, the concentration-response curves for 5-CT and 8-OH-DPAT were right-shifted relative to those for 5-HT (Fig. 1, Table 1). Suma produced no significant contractile effect in Com segments from any experimental group. As shown in Table 1, the relative order of agonist potency was 5-HT > 5-CT and 5-HT > 8-OH-DPAT in Com arteries from all experimental groups, although the relation between 5-CT and 8-OH-DPAT potency in the Com segments varied with group. Com Emax values followed the same general pattern observed for pD2: 5-HT > 5-CT and 5-HT > 8-OH-DPAT, with relation between 5-CT and 8-OH-DPAT varying among the different experimental groups (Table 2).


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 1.   Concentration-response relations for 5-hydroxytryptamine (5-HT), 5-carboxamidotryptamine (5-CT), 8-hydroxy-2(di-n-propylamino)tetraline (DPAT), and sumatriptan (Suma). Cumulative additions of 5-HT, 5-CT, 8-OH-DPAT, and sumatriptan to common carotid (A), main branch middle cerebral (B), and second branch middle cerebral (C) arteries of normoxic adult sheep yielded the concentration-response relations indicated. All contractile responses are expressed as %maximum responses to K+. Suma produced no measurable response in common carotid segments from any experimental group. All values are indicated as means ± SE, and vertical error bars indicate SEs for the numbers of animals indicated in Table 1.

                              
View this table:
[in this window]
[in a new window]
 
Table 1.   Relative potencies of 5-HT receptor agonists in sheep arteries

                              
View this table:
[in this window]
[in a new window]
 
Table 2.   Maximum responses to 5-HT receptor agonists in sheep arteries

In Main segments, the concentration-response curves for 5-CT, 8-OH-DPAT, and Suma were all right-shifted relative to those for 5-HT (Fig. 1, Table 1). The relative order of agonist potencies was 5-HT > 5-CT >=  Suma >=  8-OH-DPAT in middle cerebral arteries from both the normoxic and hypoxic adult groups but was different than this in Main segments from normoxic fetuses: 5-HT >=  5-CT > Suma > 8-OH-DPAT (as indicated in Table 1, > indicates significant differences at the P < 0.05 level and >=  indicates no significant difference and P > 0.05). In regard to Emax values in Main segments, again the normoxic and hypoxic adult groups exhibited identical patterns that were 5-HT > 5-CT > 8-OH-DPAT >=  Suma. In the normoxic fetus group, this order was similar: 5-HT > 5-CT >=  8-OH-DPAT >= Suma (Table 2).

In contrast to the Com and Main segments, concentration-response curves for 5-HT, Suma, and 8-OH-DPAT were all right-shifted relative to those for 5-CT in 2BR artery segments (Fig. 1, Table 1). In this artery group, the relative order of agonist potencies was 5-CT > 5-HT > Suma > 8-OH-DPAT in normoxic adults, but was markedly different in both hypoxic adults and normoxic fetuses: 5-CT >=  5-HT >=  Suma > 8-OH-DPAT. In 2BR artery segments, the relative order of Emax values varied with experimental group and exhibited the order 5-HT > 5-CT >=  8-OH-DPAT >=  Suma in normoxic adults, but in hypoxic adults the order was 5-HT > Suma >=  5-CT >=  8-OH-DPAT, which was similar to that observed in normoxic fetuses: 5-HT > Suma >=  8-OH-DPAT >=  5-CT (Table 2).

For both 5-HT and 5-CT, agonist potencies increased progressively with the transition from Com to Main to 2BR in all experimental groups, although the magnitudes of these increases varied somewhat among the different groups. Similarly, Suma potencies also increased with the transition from Main to 2BR segments in all experimental groups. For 8-OH-DPAT, potencies did not vary consistently among artery types in the different experimental groups but tended to be least potent in Com segments and most potent in Main segments.

Antagonist affinities. As indicated in Fig. 2 and Table 3, ketanserin potently antagonized 5-HT-induced contractions, particularly in the Com segments where it exhibited subnanomolar affinities that did not vary significantly across the three experimental groups. Ketanserin pKb values against 5-HT in the Com segments were also slightly but not significantly greater than those in the Main segments in all experimental groups. Correspondingly, ketanserin pKb values within the Main segments did not vary with experimental group. In contrast, ketanserin pKb values within the 2BR segments were 2.5- to 50-fold less than those in the Main segments in all three groups, and this difference was significant in normoxic and hypoxic adults but not in normoxic fetuses. Within the 2BR segments, ketanserin pKb values were significantly greater in normoxic fetuses than in either adult group although the values within the adult groups did not differ significantly from one another.


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 2.   Effects of ketanserin, methiothepin, and GR-127935 on serotonin concentration-response relations. Shown are the effects of ketanserin, methiothepin, and GR-127935 on serotonin concentration-response relations for common carotid (A), main branch middle cerebral (B), and second branch middle cerebral (C) arteries taken from normoxic adult sheep. Concentrations of the antagonists used were adjusted for each artery type. Concentrations of ketanserin, methiothepin, and GR-127935 used in the common carotid segments were 1.0, 0.5, and 100 nM, respectively. For the main branch middle cerebral segments shown, corresponding concentrations were 2.8, 1.0, and 100 nM, respectively. For the second branch middle cerebral segments shown, concentrations were 200, 17, and 85 nM, respectively. All values are indicated as means ± SE, and vertical error bars indicate SEs for the numbers of animals indicated in Tables 1 and 3.

                              
View this table:
[in this window]
[in a new window]
 
Table 3.   Serotonergic antagonist affinities (pKb) in sheep arteries

Against 5-CT, ketanserin produced the same general pattern of results as that produced against 5-HT (Fig. 3 and Table 3). Ketanserin pKb values against 5-CT were in the subnanomolar range in all Com and Main segments, did not vary with experimental group in either artery type, and did not differ significantly between Com and Main segments within any experimental group. The ketanserin pKb values against 5-CT in the 2BR segments were all significantly lower than observed in Com and Main segments by at least 100-fold in all experimental groups. Within the 2BR segments, ketanserin pKb values against 5-CT did not vary with experimental group. It is important to note, however, that of eight experiments carried out to determine the pKb for ketanserin against 5-CT in fetal second branch segments, only three of these exhibited any effect. Against Suma-induced contractions, ketanserin had no measurable effect in any artery type from any experimental group.


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 3.   Effects of ketanserin and methiothepin on 5-CT concentration-response relations. Indicated are the effects of ketanserin and methiothepin on 5-CT concentration-response relations for common carotid (A), main branch middle cerebral (B), and second branch middle cerebral (C) arteries taken from normoxic adult sheep. Concentrations of the antagonists used were adjusted for each artery type. Concentrations of ketanserin and methiothepin used in the common carotid segments were 0.5 and 0.5 nM, respectively. For the main branch middle cerebral segments shown, corresponding concentrations were 2.7 and 2.7 nM, respectively. For the second branch middle cerebral segments shown, concentrations were 230 and 46 nM, respectively. All values are indicated as means ± SE, and vertical error bars indicate SEs for the numbers of animals indicated in Tables 1 and 3.

Methiothepin affinities against 5-HT also exhibited a pattern similar to that observed for ketanserin (Fig. 2 and Table 3). Methiothepin pKb values against 5-HT were in the subnanomolar range in all Com and Main segments and did not differ significantly between Com and Main segments within any experimental group, although the values in the Main segments tended to be greater than those in the Com segments in all groups. Methiothepin pKb values did not differ significantly among the experimental groups in Com segments, but in Main segments the values obtained in normoxic fetuses were slightly but significantly less than observed in the normoxic adults. Methiothepin pKb values against 5-HT in the 2BR segments were all significantly less than in corresponding Main segments, and these differences averaged 25-fold in the normoxic adults, 8-fold in the hypoxic adults, but just 3-fold in the normoxic fetuses.

Against 5-CT, methiothepin affinities were more variable than observed against 5-HT (Fig. 3 and Table 3). In the Com segments, the pKb values were again in the subnanomolar range and did not vary significantly among the different experimental groups. In the Main segments, the pKb values were 5-fold less in normoxic adults, 3-fold greater in hypoxic adults, but 20-fold less in normoxic fetuses than observed in corresponding Com segments. Only the latter difference was statistically significant. Interestingly, methiothepin pKb values against 5-CT did not differ significantly between Main and 2BR segments in any experimental group and did not vary with experimental group in either artery type.

Consistent with observations made in other preparations (6, 25), both ketanserin and methiothepin exhibited some noncompetitive character against 5-HT and 5-CT (Figs. 2 and 3). These effects were most evident for methiothepin against 5-HT and 5-CT in the main branch middle cerebral but were also apparent for ketanserin against 5-CT in the main branch middle cerebral. In light of these effects, all calculations of pKb values were not based on pD2 shifts, which assume no effect on maximum response, but instead were based on dose-ratio analyses, which make no assumptions about possible effects on maximum response. These noncompetitive effects were not apparent in all arteries and were completely absent for the antagonists GR-127935 and SB-206553.

For the antagonist GR-127935, pKb values against 5-HT were low and ranged from 7.1 to 7.7 across all experimental groups (Figs. 2 and 4). These values did not differ significantly between artery types in any experimental group and also did not vary significantly with experimental group within any artery type. Against Suma, GR-127935 pKb values were somewhat greater and ranged from 7.5 to 8.5. However, again these values did not differ significantly between artery types in any experimental group and also did not vary significantly with experimental group within any artery type.


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 4.   Effects of GR-127935 on Suma concentration-response relations. Shown are the effects of GR-127935 on sumatriptan concentration-response relations for main branch middle cerebral (A) and second branch middle cerebral (B) arteries taken from normoxic adult sheep. Concentrations of GR-127935 used were adjusted for each artery type and were 92 and 49 nM for the main branch middle cerebral and second branch middle cerebral segments, respectively. All values are indicated as means ± SE, and vertical error bars indicate SEs for the numbers of animals indicated in Tables 1 and 3.

In the Com segments, the antagonist SB-206553 only weakly antagonized 5-HT-induced contractions, with pKb values averaging from 7.2 to 7.6 (Table 3). These values did not differ significantly among the three experimental groups.

    DISCUSSION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

The present experiments address the general hypothesis that changes in reactivity to 5-HT associated with maturation, acclimatization to chronic hypoxia, and differences in artery type involve differences in the receptor subtype mediating vasoconstrictor responses to 5-HT. As indicated by measurements of both relative agonist potency and antagonist affinity, the data suggest that 1) the receptors mediating responses to 5-HT changed from predominantly the 5-HT2a subtype in large Com arteries to a mixed 5-HT1/5-HT2 population in Main arteries to a predominantly 5-HT1 population in second branch segments of the middle cerebral arteries of adult sheep; 2) in small cerebral arteries the receptor mediating responses to 5-HT changed from a mixed 5-HT2/5-HT1-like population in term fetuses to a predominantly 5-HT1 population in adults; and 3) chronic hypoxia has little if any effect on 5-HT receptor type in adult carotid and cerebral arteries.

Serotonergic receptor type in ovine Com. In Com segments from all experimental groups, 5-HT was a more potent contractile agonist than 5-CT, 8-OH-DPAT, or Suma (Table 1). In addition, maximum contractile responses in the Com were far greater for 5-HT than any other agonist tested in all experimental groups (Table 2). Together, these data are consistent with the presence of the 5-HT2 receptor type according to the criteria of Hoyer et al. (18, 19). The absence of any contractile response to Suma, an agonist at the 1B, 1D, and 1F subtypes (2, 18, 19), suggests that these subtypes may not be present in the ovine Com. The low potency of 8-OH-DPAT further argues against the presence of the 1A subtype in Com segments, particularly in normoxic and hypoxic adults.

The subnanomolar affinities observed for ketanserin against 5-HT in Com segments (Table 3) also suggest the presence of the 5-HT2 receptor type (18, 19). Given that ketanserin generally exhibits near micromolar affinities against most other serotonin receptors, the high affinity of ketanserin against 5-CT observed in Com arteries suggests that these responses to 5-CT were mediated by action on 5-HT2 receptors. Consistent with this interpretation, 5-CT exhibited low potency in the present experiments (pD2 approx  5.3) and in other experiments has been shown to activate 5-HT2 receptors with low affinity (pKi approx  4.7) (18).

Whereas ketanserin exhibits high affinity toward the 5-HT2 receptor, the antagonist GR-127935 exhibits much lower affinities (pKi approx  7) toward this receptor but much higher affinities toward the 5-HT1B and 5-HT1D subtypes (pKi approx  9-10) (36). In the present study, the affinities (pKb) observed for GR-127935 against 5-HT ranged from 7.1 to 7.5 across all experimental groups, thus again arguing in support of the presence of the 5-HT2 and against the 5-HT1B and 5-HT1D receptor types in ovine Coms.

The methiothepin affinities observed were also consistent with the presence of the 5-HT2 receptor type in the ovine Com. Similar to ketanserin, methiothepin generally exhibits near nanomolar affinities for the 5-HT2 receptor, but unlike ketanserin, methiothepin also exhibits submicromolar affinities (7.7-8.1) against most 5-HT1 receptor types (18). The high pKb values observed for methiothepin against 5-HT (9.2-9.5) and also against 5-CT (9.1-9.9) are consistent with the presence of the 5-HT2 receptor type.

Given that the 5-HT2 family includes three different subtypes (2A, 2B, and 2C), we used the antagonist SB-206553 to help determine which of these subtypes were present. As recently shown by Kennett et al. (21), this antagonist has 50- to 100-fold greater affinity toward the 2B and 2C subtypes (pKi approx  9) than for the 2A subtype (pKi approx  7.3). Thus the relatively low pKb values (7.2-7.6) obtained for SB-206553 against 5-HT in the Coms argue against the presence of the 2B and 2C subtypes. Additional support for this interpretation is provided by the finding that mRNA for the 2C subtype is generally not found in extracranial tissues (1, 39). Furthermore, the affinity for ketanserin against the 2B subtype is also much lower (pKi approx  5-6) (22) than observed in the present studies (pKb approx 9). Together, the combined agonist and antagonist data strongly suggest that contractile responses to 5-HT in ovine Com arteries are mediated primarily by the 5-HT2A receptor subtype.

Serotonergic receptor type in ovine Main. In the Main segments, the relative order of agonist potencies was similar to that observed in the Com segments, with the main exception that Suma produced significant contractile responses, suggesting the presence of an additional receptor type (Table 1), although the order of agonist potency was consistent with the predominance of the 5-HT2 receptor type in Main segments (18). Another indication that a second receptor type might be involved was provided by the observation that 5-CT potency was at least eightfold greater in Main segments than in Com segments, across all experimental groups (Table 1). The potencies observed for 5-CT (pD2 approx  6.2-6.9), however, were still much lower than typically observed for 5-CT at most 5-HT1 type receptors (7.9-8.6) (18), a result that might be expected if 5-CT were acting simultaneously with high affinity on 5-HT1 receptors and with low affinity on 5-HT2 receptors.

Given that the 5-HT1A receptor is rarely expressed in arterial smooth muscle (18, 39) and that the potency observed for 8-OH-DPAT (pD2 approx  5.6-5.7) was markedly less than typical of interaction at 1A receptors (pD2 approx  8.2), but was consistent with interaction at other 5-HT1B, 5-HT1D, or 5-HT2 receptors (pD2 approx  5-7) (18), the data were more consistent with the presence of the 1B or 1D subtype than with the presence of the 1A subtype. To evaluate the possible presence of the 1B/1D subtypes, pKb values were measured for the antagonist GR-127935 against both 5-HT- and Suma-induced contractions. Against 5-HT, these pKb values ranged from 7.4 to 7.7, values much lower than typical of interaction of GR-127935 with 1B or 1D receptors (8.5-10) but were typical of interaction with the 5-HT2A subtype (pKi approx  7.4) (36). Against Suma, however, the affinities for GR-127935 were significantly greater (8.1-8.5) than against 5-HT but were still too low to suggest the presence of the human 1B (pKi approx  9.9) or 1D (pKi approx  8.9) receptor subtypes (36). Alternatively, the range of values observed was consistent with the presence of the rat 1B receptor type (pKi approx  8.5) (36). In further support of this interpretation, the potencies observed for Suma (pD2 approx  5.9-6.4) were also not typical of interaction with the 1D or h1B subtypes (pD2 approx  8.1-8.4) but were compatible with the presence of the r1B subtype (pD2 approx  6.3) (30). Previous studies have also concluded that the 5-HT1B subtype is present in both bovine and human middle cerebral arteries (14). Thus the combined agonist and antagonist data are consistent with the interpretation that contractile responses to 5-HT in ovine Main arteries are mediated by a mixed population of 5-HT1 (possibly the r1B) and 5-HT2 receptors as previously suggested by Gaw et al. (13), and by Hamel et al. (15) for cat cerebral arteries and by Parsons and Whalley (31) for the rabbit basilar arteries.

Serotonergic receptor type in ovine 2BR. In contrast to the Com and Main arteries, 2BR arteries from normoxic adults contracted with greatest sensitivity to 5-CT, and their relative order of agonist potencies was 5-CT > 5-HT > Suma > 8-OH-DPAT (Table 1). Although the results of statistical comparisons among the different agonists varied somewhat with experimental group, the same basic order of agonist potencies was observed in all groups. This order suggests that the 5-HT1 type was predominant in 2BR arteries. Consistent with this interpretation, ketanserin affinities (Table 3) against 5-HT (pKb = 7.4) and 5-CT (pKb approx  7.2) in the normoxic adult second branch arteries were markedly less than typical of interaction at a 5-HT2 receptor (pKb approx  9) and more consistent with interaction at either a 5-HT1D (pKi approx  7.4) (44) or a mixed population of 5-HT1B (pKd approx  5.7) or 5-HT1A (pKd approx  5.9) and 5-HT2 subtypes (17). In addition, the mixed 5-HT1/5-HT2 antagonist methiothepin exhibited 16-fold greater affinity than ketanserin against 5-HT and 8-fold greater affinity against 5-CT. The methiothepin affinities observed against 5-HT (pKb = 8.6) and 5-CT (8.1), however, were much greater than their values at the 1A, 1B, or 1D subtypes (pKd approx  7.1-7.3) and slightly less than their affinity against the 5-HT2 subtype (pKd approx  8.8). Together, these data suggest the possible presence of a mixed 5-HT1/5-HT2 receptor population with predominance of the 5-HT1 subtype.

To help evaluate which 5-HT1 subtype was involved in 5-HT-induced contractions of the 2BR arteries, we determined pKb values for the antagonist GR-127935. The pKb values obtained in second branch preparations from normoxic adults against 5-HT (7.7) were much lower than typical of interactions with the r1B (pKi approx  8.5), h1B (pKi approx  9.9), or 1D (pKi approx  8.9) receptors and were much more typical of interaction with the 5-HT2A (pKi approx  7.4) (36), again suggesting the possible presence of 5-HT2 receptors. Interestingly, the pKb values obtained for GR-127935 against Suma (7.7) were identical to those obtained against 5-HT. Given that Suma has extremely low affinity toward the 5-HT2 receptor (pKa approx  3.7-4.1) (35), it is unlikely that the contractions induced by Suma (pD2 approx  6.6) involved 5-HT2 receptors, and thus it seems unlikely that the low pKb value obtained for GR-127935 against Suma (7.7) was due to involvement of 5-HT2 receptors. Given that the apparent affinity of GR-127935 was the same against 5-HT and Suma, it remains possible that 5-HT and Suma activated the same receptor, as previously proposed by Parsons and Whalley (31) based on similar studies in the rabbit basilar artery. Although the nature of the 5-HT1 receptor involved in the present studies remains uncertain, it is unlikely to be the 1A given the low potency (pD2 approx  5.6) exhibited in 2BRs. In turn, the potency exhibited by Suma in the second branch preparations (pD2 approx  6.6) was more consistent with interaction at the r1B subtype (pD2 approx  6.3) than with the 1D or h1B subtypes (pD2 approx  8.1-8.4) (30). In either event, the overall data support the view that contractile responses to 5-HT in 2BR arteries from normoxic adults are mediated predominantly by 5-HT1 receptors (possibly the r1B), with a possible contribution from a less dominant population of 5-HT2 receptors.

Effects of hypoxic acclimatization and maturation on 5-HT receptor type. A recurrent feature of many studies of the effects of high-altitude acclimatization include significant alterations in the reactivity of many vascular beds, a response we have demonstrated in the ovine cerebral circulation (26). Because receptor type is a key determinant of overall vasoreactivity, it seems reasonable to suspect that the receptor type mediating responses to 5-HT might change during high-altitude acclimatization. The present data, however, argue against this possibility. Aside from the typical (26) significant generalized increases in Emax that we observed in the Coms and Mains in hypoxic compared with normoxic adults (Table 2), there were no major differences in either agonist potencies (Table 1) or antagonist affinities (Table 3) between normoxic and hypoxic adults. Together these findings suggest that the changes in vascular reactivity associated with hypoxic acclimatization probably do not involve changes in receptor type, but rather changes in the coupling of the receptors to the contractile apparatus.

Compared with the general lack of effect of hypoxic acclimatization on 5-HT receptor type, maturation had a somewhat greater effect, which was most pronounced in the 2BR artery segments. In the normoxic fetus, the relative order of agonist potencies was essentially the same in the second branch segments as observed in the normoxic adult (Table 1), although maximum responses were somewhat depressed, particularly for 5-CT and 8-OH-DPAT. More importantly, ketanserin affinities against 5-HT were 25-fold greater in the fetus (pKb approx  8.8) than in the adult (pKb approx  7.4), suggesting much greater 5-HT2 character in the fetal second branch arteries (Table 3). Against 5-CT, ketanserin affinities were also much less in the fetus (pKb approx  6.7) than in the adult (pKb approx  7.2), although this difference was not significant. It is important to note, however, that the majority (5 of 8) of attempts to determine the ketanserin pKb against 5-CT yielded no measurable effect, suggesting that the receptor type at which 5-CT and ketanserin were interacting in the adult segments was either absent or present only in reduced abundance in the fetus. Despite this difference, no significant age-related differences in pKb values were observed for any other antagonist in the second branch segments. Overall, the combined agonist and antagonist data suggest that in the normoxic fetus, as in the adult, contractile responses to 5-HT in the 2BR are mediated by a mixed population of 5-HT1 (possibly the r1B) and 5-HT2 receptors and the relative proportion of 5-HT2 receptors is greater in the fetus than in the adult.

In the Main segments from the fetus, the relative order of agonist potencies was identical to that in the adult (Table 1), and the only significant difference in antagonist affinities was that methiothepin affinity against 5-HT was depressed in the fetus (pKb approx  9.3) relative to the adult (pKb approx  10.0). In the Com arteries, there were no age-related differences in antagonist affinities (Table 3), but agonist potencies (Table 1) and maximum responses (Table 2) tended to be generally greater in the fetus than the adult, reflecting the well-established influence of maturation on vasoreactivity (16, 33). These minor age-related differences not withstanding, the overall distribution of serotonergic receptor subtypes was therefore basically the same in the fetus and adult, with the exception that the second branch arteries exhibited greater 5-HT2 character in the fetus.

Physiological significance of shifts in serotonergic receptor type. The present suggestion of a transition from the 5-HT2a subtype in the larger and more proximal Com, to a mixed 5-HT1/5-HT2 population with 5-HT2 predominance in the Main segments, to a mixed 5-HT1/5-HT2 population with 5-HT1 predominance in the 2BR is similar to patterns suggested in other vascular beds. In rabbit aorta (9) and carotid artery (43), 5-HT-induced contractions are mediated by the 5-HT2 receptor, whereas in the smaller mesenteric (42) and basilar arteries (31), a mixed receptor population of 5-HT2 and 5-HT1 receptors mediates responses to 5-HT. At the level of the rabbit middle cerebral artery, the responses to 5-HT are mediated predominantly by the 5-HT1-like and/or 5-HT1d receptor subtypes (8). In addition, the distribution of alpha -adrenergic receptor subtypes has also been shown to vary with artery diameter and tends to shift from the alpha 1-subtype in larger arteries to a mixed alpha 1- and alpha 2-population in intermediately sized arteries, to predominantly the alpha 2-subtype in terminal arterioles (23, 24). The present findings are thus consistent with a broad variety of evidence suggesting an artery size-related shift in predominant receptor subtype.

A key difference among the characteristics of the receptors mediating contractile responses to 5-HT in small and large arteries is the signal transduction pathway involved. The 5-HT2 receptor involved in large arteries is coupled to the synthesis and release of inositol trisphosphate, which in turn stimulates the release of intracellular calcium (34). The same is true of the alpha 1-receptor type also predominant in large arteries. In contrast, the 5-HT1 receptors present in small arteries are coupled to decreases in cAMP, membrane depolarization, and subsequent entry of calcium from the extracellular space (12, 37). Again, the alpha 2-receptor predominant in small arteries also uses a similar signal transduction pathway. Thus the receptor type in large arteries most typically stimulates the release of intracellular calcium, whereas the receptor type in small arteries typically stimulates the entry of extracellular calcium. Correspondingly, intracellular stores of calcium are generally much greater and well developed in large than in small arteries (11). Certainly, other factors related to artery size and type, such as differences in electrophysiological characteristics (29), calcium sensitivity (4), and cyclic nucleotide metabolism (32) may also in some way influence and/or reflect different receptor distribution among arteries of differing type and size. Nonetheless, the 5-HT receptor type predominant in ovine cranial arteries appears closely related to the relative dependence on intracellular release, compared with extracelluar influx, as a source of activator calcium.

In parallel with the effects of changing artery size and type on receptor type, maturation further involves a generalized decreased reliance on extracellular calcium entry and an increased reliance on intracellular calcium release in many tissues (45). This general finding would predict that maturation would thus also involve a shift from the 5-HT1-like receptor type, which depends more on extracellular calcium entry, to the 5-HT2 type, which depends more on intracellular release. The fact that this shift was not observed, however, suggests at least three possibilities. First, the ability of Com and Main arteries to store and release intracellular calcium may be sufficient to mediate contractile responses to 5-HT in the term fetus. A second possibility is that the generally greater receptor densities typical of many receptor types in immature cerebral arteries (27) may in some way compensate for a decreased ability to release intracellular calcium. Third, the diacylglycerol released in tandem with inositol trisphosphate in response to 5-HT2 stimulation may play a more significant role in increasing extracellular entry (40, 41) and or increased calcium sensitivity (3) in the fetal compared with adult arteries. Consistent with this possibility, protein kinase C activity, which is stimulated by diacylglycerol, is generally greater in fetal than adult vascular tissues (7). At present, the relative importance of each of these possibilities remains uncertain, particularly in the 2BR artery segments where maturation appeared to decrease the presence of 5-HT2 receptors. Clearly, additional experiments will be required to differentiate among these possibilities.

Perspectives

The distribution of contractile 5-HT receptor types appears closely related to artery size and vascular bed of origin such that the ratio of 5-HT2 to 5-HT1 receptor densities is highest in the larger more proximal arteries and lowest in the smaller and more distal arteries of the ovine cerebral circulation. This pattern thus places the 5-HT2 receptor, which typically mobilizes intracellular calcium, predominantly in arteries containing the largest intracellular calcium stores (Com) and also places the 5-HT1 receptor, which is less dependent on intracellular calcium mobilization for contraction, predominantly in arteries with the smallest intracellular calcium stores (the 2BR). Given that this pattern of receptor distribution appears stable during maturation and hypoxic acclimatization, shifts in agonist potency and maximum response associated with these perturbations must be achieved through modulation of coupling efficiency and/or receptor density instead of changes in receptor type. How the observed patterns of 5-HT receptor distribution influence vasoreactivity, in vivo, however, remains somewhat uncertain because the present results were obtained in endothelium-denuded preparations and the endothelium may also be populated with 5-HT receptors of varying types (39) that potentially could be distributed in relation to artery type or size. Vasodilatory 5-HT receptors such as the 5-HT4 or 5-HT7 types (19, 39) might also contribute to integrated in vivo responses. Nonetheless, the present results emphasize that serotonergic receptor type in ovine cranial arteries varies in relation to the functional and morphological characteristics of different artery types but does not appear to change extensively during homeostatic adjustments to developmental or environmental change.

    ACKNOWLEDGEMENTS

The authors greatly appreciate the helpful comments of Dr. Edith Hamel regarding the interpretation of the data in this manuscript.

    FOOTNOTES

The work reported here was supported by National Heart, Lung, and Blood Institute (NHLBI) Grant HL-54120 (to W. J. Pearce), National Institute of Child Health and Human Development Grant HD-31266 (to W. J. Pearce), NHLBI Grant HL-54094 (to L. Zhang), and the Loma Linda University School of Medicine.

Address for reprint requests: W. J. Pearce, Center for Perinatal Biology, Loma Linda Univ. School of Medicine, Loma Linda, CA 92350.

Received 28 July 1997; accepted in final form 12 May 1998.

    REFERENCES
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

1.   Abramowski, D., M. Rigo, D. Duc, D. Hoyer, and M. Staufenbiel. Localization of the 5-hydroxytryptamine2C receptor protein in human and rat brain using specific antisera. Neuropharmacology 34: 1635-1645, 1995[Medline].

2.   Adham, N., H. T. Kao, L. E. Schecter, J. Bard, M. Olsen, D. Urquhart, M. Durkin, P. R. Hartig, R. L. Weinshank, and T. A. Branchek. Cloning of another human serotonin receptor (5-HT1F): a fifth 5-HT1 receptor subtype coupled to the inhibition of adenylate cyclase. Proc. Natl. Acad. Sci. USA 90: 408-412, 1993[Abstract/Free Full Text].

3.   Akopov, S. E., L. Zhang, and W. J. Pearce. Physiological variations in ovine cerebrovascular calcium sensitivity. Am. J. Physiol. 272 (Heart Circ. Physiol. 41): H2271-H2281, 1997[Abstract/Free Full Text].

4.   Boels, P. J., M. Troschka, J. C. Ruegg, and G. Pfitzer. Higher Ca2+ sensitivity of triton-skinned guinea pig mesenteric microarteries as compared with large arteries. Circ. Res. 69: 989-996, 1991[Abstract/Free Full Text].

5.   Bonvento, G., E. T. MacKenzie, and L. Edvinsson. Serotonergic innervation of the cerebral vasculature: relevance to migraine and ischaemia. Brain Res. Brain Res. Rev. 16: 257-263, 1991[Medline].

6.   Chang, J. Y., and C. Owman. Cerebrovascular serotonergic receptors mediating vasoconstriction: further evidence for the existence of 5-HT2 receptors in rat and 5-HT1-like receptors in guinea-pig basilar arteries. Acta Physiol. Scand. 136: 59-67, 1989[Medline].

7.   Das, M., K. R. Stenmark, and E. C. Dempsey. Enhanced growth of fetal and neonatal pulmonary artery adventitial fibroblasts is dependent on protein kinase C. Am. J. Physiol. 269 (Lung Cell. Mol. Physiol. 13): L660-L667, 1995[Abstract/Free Full Text].

8.   Deckert, V., D. Pruneau, and J. L. Elghozi. Mediation by 5-HT1D receptors of 5-hydroxytryptamine-induced contractions of rabbit middle and posterior cerebral arteries. Br. J. Pharmacol. 112: 939-945, 1994[Medline].

9.   De la Lande, I. S. Evidence for a 5-HT1-like receptor mediating the amplifying action of 5-HT in the rabbit ear artery. Br. J. Pharmacol. 107: 550-555, 1992[Medline]. 106: 1992, p. 550-555.]

10.   Elliott, S. R., and W. J. Pearce. Effects of maturation on alpha -adrenergic receptor affinity and occupancy in small cerebral arteries. Am. J. Physiol. 267 (Heart Circ. Physiol. 36): H757-H763, 1994[Abstract/Free Full Text].

11.   Franco-Obergón, A., and J. López-Barneo. Differential oxygen sensitivity of calcium channels in rabbit smooth muscle cells of conduit and resistance pulmonary arteries. J. Physiol. (Lond.) 491: 511-518, 1996[Abstract/Free Full Text].

12.   Garland, C. J. The role of membrane depolarization in the contractile response of the rabbit basilar artery to 5-hydroxytryptamine. J. Physiol. (Lond.) 392: 333-348, 1987[Abstract/Free Full Text].

13.   Gaw, A. J., R. M. Wadsworth, and P. P. Humphrey. Pharmacological characterisation of postjunctional 5-HT receptors in cerebral arteries from the sheep. Eur. J. Pharmacol. 179: 35-44, 1990[Medline].

14.   Hamel, E., E. Fan, D. Linville, V. Ting, J. G. Villemure, and L. S. Chia. Expression of mRNA for the serotonin 5-hydroxytryptamine 1D beta receptor subtype in human and bovine cerebral arteries. Mol. Pharmacol. 44: 242-246, 1993[Abstract].

15.   Hamel, E., J. P. Robert, A. R. Young, and E. T. MacKenzie. Pharmacological properties of the receptor(s) involved in the 5-hydroxytryptamine-induced contraction of the feline middle cerebral artery. J. Pharmacol. Exp. Ther. 249: 879-889, 1989[Abstract/Free Full Text].

16.   Hayashi, S., M. K. Park, and T. J. Kuehl. Relaxant and contractile responses to prostaglandins in premature, newborn and adult baboon cerebral arteries. J. Pharmacol. Exp. Ther. 233: 628-635, 1985[Abstract/Free Full Text].

17.   Hoyer, D. 5-Hydroxytryptamine receptors and effector coupling mechanisms in peripheral tissues. In: The Peripheral Actions of 5-Hydroxytryptamine, edited by J. R. Fozard. Oxford: Oxford Medical, 1989, p. 72-99.

18.   Hoyer, D., D. E. Clarke, J. R. Fozard, P. R. Hartig, G. R. Martin, E. J. Mylecharane, P. R. Saxena, and P. P. Humphrey. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev. 46: 157-203, 1994[Abstract].

19.   Hoyer, D., and G. R. Martin. Classification and nomenclature of 5-HT receptors: a comment on current issues. Behav. Brain Res. 73: 263-268, 1996[Medline].

20.   Hull, A. D., D. M. Long, L. D. Longo, and W. J. Pearce. Pregnancy-induced changes in ovine cerebral arteries. Am. J. Physiol. 262 (Regulatory Integrative Comp. Physiol. 31): R137-R143, 1992[Abstract/Free Full Text].

21.   Kennett, G. A., M. D. Wood, F. Bright, J. Cilia, D. C. Piper, T. Gager, D. Thomas, G. S. Baxter, I. T. Forbes, P. Ham, and T. P. Blackburn. In vitro and in vivo profile of SB 206553, a potent 5-HT2C/5-HT2B receptor antagonist with anxiolytic-like properties. Br. J. Pharmacol. 117: 427-434, 1996[Medline].

22.   Kursar, J. D., D. L. Nelson, D. B. Wainscott, and M. Baez. Molecular cloning, functional expression, and mRNA tissue distribution of the human 5-hydroxytryptamine2B receptor. Mol. Pharmacol. 46: 227-34, 1994[Abstract].

23.  Langer, S. Z., and P. E. Hicks. Alpha-adrenoceptors subtypes in blood vessels: physiology and pharmacology. J. Cardiovasc. Pharmacol. 6, Suppl. 4: S547-S558, 1984.

24.   Leech, C. J., and J. E. Faber. Different alpha -adrenoceptor subtypes mediate constriction of arterioles and venules. Am. J. Physiol. 270 (Heart Circ. Physiol. 39): H710-H722, 1996[Abstract/Free Full Text].

25.   Lemoine, H., and A. J. Kaumann. Allosteric properties of 5-HT2 receptors in tracheal smooth muscle. Naunyn Schmiedebergs Arch. Pharmacol. 333: 91-97, 1986[Medline].

26.   Longo, L. D., A. D. Hull, D. M. Long, and W. J. Pearce. Cerebrovascular adaptations to high-altitude hypoxemia in fetal and adult sheep. Am. J. Physiol. 264 (Regulatory Integrative Comp. Physiol. 33): R65-R72, 1993[Abstract/Free Full Text].

27.   Longo, L. D., N. Ueno, Y. Zhao, L. Zhang, and W. J. Pearce. NE-induced contraction, alpha 1-adrenergic receptors, and Ins(1,4,5)P3 responses in cerebral arteries. Am. J. Physiol. 270 (Heart Circ. Physiol. 39): H915-H923, 1996[Abstract/Free Full Text].

28.   MacKenzie, E. T., L. Edvinsson, and B. Scatton. Functional bases for a central serotonergic involvement in classic migraine: a speculative view. Cephalalgia 5: 69-78, 1985[Medline].

29.   Nelson, M. T., J. G. McCarron, and J. M. Quayle. Ion channels in resistance arteries. In: The Resistance Vasculature, edited by J. A. Bevan, W. Halpern, and M. J. Mulvany. Totowa, NJ: Humana, 1991, p. 265-279.

30.   Parker, E. M., D. A. Grisel, L. G. Iben, and R. A. Shapiro. A single amino acid difference accounts for the pharmacological distinctions between the rat and human 5-hydroxytryptamine 1B receptors. J. Neurochem. 60: 380-383, 1993[Medline].

31.   Parsons, A. A., and E. T. Whalley. Evidence for the presence of 5-HT1-like receptors in rabbit isolated basilar arteries. Eur. J. Pharmacol. 174: 189-196, 1989[Medline].

32.   Pearce, W. J., and S. R. Elliott. Maturation enhances the sensitivity of ovine cerebral arteries to the ATP-sensitive potassium channel activator lemakalim. Pediatr. Res. 35: 729-732, 1994[Medline].

33.   Pearce, W. J., A. D. Hull, D. M. Long, and L. D. Longo. Developmental changes in ovine cerebral artery composition and reactivity. Am. J. Physiol. 261 (Regulatory Integrative Comp. Physiol. 30): R458-R465, 1991[Abstract/Free Full Text].

34.   Roth, B. L., T. Nakaki, D. M. Chuang, and E. Costa. 5-Hydroxytryptamine2 receptors coupled to phospholipase C in rat aorta: modulation of phosphoinositide turnover by phorbol ester. J. Pharmacol. Exp. Ther. 238: 480-485, 1986[Abstract/Free Full Text].

35.   Schoeffter, P., and D. Hoyer. How selective is GR 43175? Interactions with functional 5-HT1A, 5-HT1B, 5-HT1C and 5-HT1D receptors. Naunyn Schmiedebergs Arch. Pharmacol. 340: 135-138, 1989[Medline].

36.   Skingle, M., D. T. Beattie, D. I. Scopes, S. J. Starkey, H. E. Connor, W. Feniuk, and M. B. Tyers. GR127935: a potent and selective 5-HT1D receptor antagonist. Behav. Brain Res. 73: 157-161, 1996[Medline].

37.   Sumner, M. J., W. Feniuk, J. D. McCormick, and P. P. Humphrey. Studies on the mechanism of 5-HT1 receptor-induced smooth muscle contraction in dog saphenous vein. Br. J. Pharmacol. 105: 603-608, 1992[Medline].

38.   Szabo, C., K. Emilsson, J. E. Hardebo, S. Nystedt, and C. Owman. Uptake and release of serotonin in rat cerebrovascular nerves after subarachnoid hemorrhage. Stroke 23: 54-61, 1992[Abstract/Free Full Text].

39.   Ullmer, C., K. Schmuck, H. O. Kalkman, and H. Lubbert. Expression of serotonin receptor mRNAs in blood vessels. FEBS Lett. 370: 215-221, 1995[Medline].

40.   Wetzel, G. T., F. Chen, W. F. Friedman, and T. S. Klitzner. Calcium current measurements in acutely isolated neonatal cardiac myocytes. Pediatr. Res. 30: 83-88, 1991[Medline].

41.   Wetzel, G. T., F. Chen, and T. S. Klitzner. Na+/Ca2+ exchange and cell contraction in isolated neonatal and adult rabbit cardiac myocytes. Am. J. Physiol. 268 (Heart Circ. Physiol. 37): H1723-H1733, 1995[Abstract/Free Full Text].

42.   Yildiz, O., and M. Tuncer. 5-HT1-like and 5-HT2A receptors mediate 5-hydroxytryptamine-induced contraction of rabbit isolated mesenteric artery. Naunyn Schmiedebergs Arch. Pharmacol. 352: 127-131, 1995[Medline].

43.   Yildiz, O., and M. Tuncer. Comparison of the effect of endothelium on the responses to sumatriptan in rabbit isolated iliac, mesenteric and carotid arteries. Arch. Int. Pharmacodyn. Ther. 328: 200-212, 1994[Medline].

44.   Zgombick, J. M., L. E. Schechter, S. A. Kucharewicz, R. L. Weinshank, and T. A. Branchek. Ketanserin and ritanserin discriminate between recombinant human 5-HT1D alpha and 5-HT1D beta receptor subtypes. Eur. J. Pharmacol. 291: 9-15, 1995[Medline].

45.   Zurcher, S. D., and W. J. Pearce. Maturation modulates serotonin- and potassium-induced calcium-45 uptake in ovine carotid and cerebral arteries. Pediatr. Res. 38: 493-500, 1995[Medline].


Am J Physiol Regul Integr Compar Physiol 275(3):R742-R753
0002-9513/98 $5.00 Copyright © 1998 the American Physiological Society



This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. J. Sandoval, E. R. Injeti, W. T. Gerthoffer, and W. J. Pearce
Postnatal maturation modulates relationships among cytosolic Ca2+, myosin light chain phosphorylation, and contractile tone in ovine cerebral arteries
Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2183 - H2192.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. M. Charles, L. Zhang, L. D. Longo, J. N. Buchholz, and W. J. Pearce
Postnatal maturation attenuates pressure-evoked myogenic tone and stretch-induced increases in Ca2+ in rat cerebral arteries
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2007; 293(2): R737 - R744.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
W. Pearce
Hypoxic regulation of the fetal cerebral circulation
J Appl Physiol, February 1, 2006; 100(2): 731 - 738.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
S. M. Nauli, J. M. Williams, W. T. Gerthoffer, and W. J. Pearce
Chronic hypoxia modulates relations among calcium, myosin light chain phosphorylation, and force differently in fetal and adult ovine basilar arteries
J Appl Physiol, July 1, 2005; 99(1): 120 - 127.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
L. D. Longo and W. J. Pearce
Fetal cerebrovascular acclimatization responses to high-altitude, long-term hypoxia: a model for prenatal programming of adult disease?
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2005; 288(1): R16 - R24.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
G. G. Geary, J. N. Buchholz, and W. J. Pearce
Maturation depresses mouse cerebrovascular tone through endothelium-dependent mechanisms
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2003; 284(3): R734 - R741.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. M. Nauli, L. Zhang, and W. J. Pearce
Maturation depresses cGMP-mediated decreases in [Ca2+]i and Ca2+ sensitivity in ovine cranial arteries
Am J Physiol Heart Circ Physiol, March 1, 2001; 280(3): H1019 - H1028.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
D. M. Angeles, J. Williams, R. E. Purdy, L. Zhang, and W. J. Pearce
Effects of maturation and acute hypoxia on receptor-IP3 coupling in ovine common carotid arteries
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2001; 280(2): R410 - R417.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. M. Angeles, J. Williams, L. Zhang, and W. J. Pearce
Acute hypoxia modulates 5-HT receptor density and agonist affinity in fetal and adult ovine carotid arteries
Am J Physiol Heart Circ Physiol, August 1, 2000; 279(2): H502 - H510.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Teng, G. Q.
Right arrow Articles by Pearce, W. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Teng, G. Q.
Right arrow Articles by Pearce, W. J.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online